India is struggling to export its surplus of Covid-19 vaccines as logistical hurdles delay their use in many countries despite low levels of inoculation, vaccine producer the Serum Institute of India (SII) and a government official said on Tuesday. The SII, the world's biggest vaccine maker that produces the AstraZeneca, Novavax and Sputnik Covid-19 shots, has already
NEW DELHI (Reuters) - India is struggling to export its surplus of COVID-19 vaccines as logistical hurdles delay their use in many countries despite low levels of inoculation, vaccine producer the Serum Institute of India (SII) and a government official said on Tuesday.
New Delhi: India is struggling to export its surplus of COVID 19 vaccines as logistical hurdles delay their use in many countries despite low levels o.
GENEVA: The global vaccine alliance, Gavi, said on Thursday that its board had approved an initial $155.7 million for the roll-out of the first malaria vaccine for children in sub-Saharan Africa.